← Leaderboards
Jena J Steinle
Wayne State University
$7,755,059
Attributed
$7,755,059
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $917.1K · FY2006–24$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,755,059 · 10
VA$0 · 1
By mechanism
R01$6,975,495 · 5
P30$592,200 · 2
R41$108,399 · 1
R15$42,560 · 1
F32$36,405 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Wayne State University
Same institution · by research overlap
- Linda D Hazlett$19,065,465
- Renu A. Kowluru$12,005,906
- Ralph E Parchment$1,893,148
- Frederick Augustus Valeriote$9,013,129
- Aleem Gangjee$13,765,845
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsRetinaSmall Interfering RnaDiabetic RetinopathyDiabeticReportingEndothelial CellsPathway InteractionsDiabetic RatPreventSignal TransductionDiabetes MellitusMediatingBlood VesselsBlindnessCytokineAgonistNeuronsResponseGlucoseCyclic Amp-Dependent Protein KinasesInflammation MediatorsCell TypeMolecular
Grant awards (33)
PKA and Epac1 inhibit TLR4 to protect the diabetic retina$351,262
R01 · FY2024 · EY · contact PI
PKA and Epac1 inhibit TLR4 to protect the diabetic retina$351,262
R01 · FY2023 · EY · contact PI
Tissue Culture/Molecular (TC/M) Core$118,440
P30 · FY2023 · EY · contact PI
PKA and Epac1 inhibit TLR4 to protect the diabetic retina$340,723
R01 · FY2022 · EY · contact PI
Tissue Culture/Molecular (TC/M) Core$118,440
P30 · FY2022 · EY · contact PI
Inhibition of HMGB1 as a protective mechanism against diabetic retinopathy$433,965
R01 · FY2021 · EY · contact PI
PKA and Epac1 inhibit TLR4 to protect the diabetic retina$340,723
R01 · FY2021 · EY · contact PI
Tissue Culture/Molecular (TC/M) Core$118,440
P30 · FY2021 · EY · contact PI
Inhibition of HMGB1 as a protective mechanism against diabetic retinopathy$447,387
R01 · FY2020 · EY · contact PI
PKA and Epac1 inhibit TLR4 to protect the diabetic retina$351,262
R01 · FY2020 · EY · contact PI
Tissue Culture/Molecular (TC/M) Core$118,440
P30 · FY2020 · EY · contact PI
Inhibition of HMGB1 as a protective mechanism against diabetic retinopathy$447,387
R01 · FY2019 · EY · contact PI
Tissue Culture/Molecular (TC/M) Core$118,440
P30 · FY2019 · EY · contact PI
Inhibition of HMGB1 as a protective mechanism against diabetic retinopathy$447,387
R01 · FY2018 · EY · contact PI
Mechanisms of TNFalpha-Induced Insulin Resistance in Retinal Cells$346,500
R01 · FY2017 · EY · contact PI
Compound 49b Prevents Retinal Endothelial Cell Death Through IGFBP-3 Levels$384,791
R01 · FY2016 · EY · contact PI
Mechanisms of TNFalpha-Induced Insulin Resistance in Retinal Cells$268,915
R01 · FY2016 · EY · contact PI
Compound 49b Prevents Retinal Endothelial Cell Death Through IGFBP-3 Levels$374,747
R01 · FY2015 · EY · contact PI
Mechanisms of TNFalpha-Induced Insulin Resistance in Retinal Cells$308,149
R01 · FY2015 · EY · contact PI
Compound 49b Prevents Retinal Endothelial Cell Death Through IGFBP-3 Levels$263,608
R01 · FY2014 · EY · contact PI
Mechanisms of TNFalpha-Induced Insulin Resistance in Retinal Cells$184,235
R01 · FY2014 · EY · contact PI
Compound 49b Prevents Retinal Endothelial Cell Death Through IGFBP-3 Levels$103,892
R01 · FY2014 · EY · contact PI
Mechanisms of TNFalpha-Induced Insulin Resistance in Retinal Cells$73,015
R01 · FY2014 · EY · contact PI
Mechanisms of TNFalpha-Induced Insulin Resistance in Retinal Cells$46,109
R01 · FY2014 · EY · contact PI
Compound 49b prevents retinal endothelial cell apoptosis in type 2 diabetes$0
I01 · FY2014 · VA · contact PI
Compound 49b Prevents Retinal Endothelial Cell Death Through IGFBP-3 Levels$337,500
R01 · FY2013 · EY · contact PI
Mechanisms of TNFalpha-Induced Insulin Resistance in Retinal Cells$262,500
R01 · FY2013 · EY · contact PI
Compound 49b prevents retinal endothelial cell apoptosis in type 2 diabetes$0
I01 · FY2013 · VA · contact PI
Compound 49b Prevents Retinal Endothelial Cell Death Through IGFBP-3 Levels$375,000
R01 · FY2012 · EY · contact PI
Novel Topical Therapy for Diabetic Retinopathy using Beta-Adrenergic Receptor Ago$108,399
R41 · FY2011 · EY · contact PI
Effects of loss of sympathetic nerve activity on normal ocular aging$135,176
R01 · FY2006 · AG · contact PI
Effects of loss of sympathetic nerve activity on normal ocular aging$42,560
R15 · FY2006 · AG · contact PI
Regulation of Angiogenesis via EphB4 Signaling$36,405
F32 · FY2002 · HL